Results 191 to 200 of about 155,020 (314)

The burden of COVID‐19 in hospitalized people with diabetes mellitus in Brazil: Insights from four years of the pandemic

Diabetic Medicine, EarlyView.
Abstract Aims Coronavirus disease 2019 (COVID‐19), caused by severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2), is more severe in people with diabetes mellitus due to immune dysfunction, exacerbated inflammation and increased risk of co‐morbidities and mortality.
Taís Mendes Camargo, Bianca Aparecida Siqueira, Luiz Felipe Azevedo Marques, Lucas Silva Mello, Fernando Augusto Lima Marson   +4 more
wiley   +1 more source

Influenza vaccine hesitancy versus uptake in seven Chinese megacities: a cross-sectional survey. [PDF]

Infect Dis Poverty
Li T, Xiong Q, Wu P.
europepmc   +1 more source

Understanding the Epidemiology of Pertussis in Denmark

Acta Paediatrica, EarlyView.
Tine Dalby, Aoife Ronayne, Peter Henrik Andersen   +2 more
wiley   +1 more source

Influenza Vaccination Among Individuals With Type 1 Diabetes in Denmark: Coverage, Persistence, and Determinants, 2015–2022

Diabetes, Obesity and Metabolism, EarlyView.
ABSTRACT Aims To investigate influenza vaccination coverage (IVC) and persistence with annual influenza vaccination among individuals with type 1 diabetes in Denmark and to identify clinical, demographic, and socioeconomic factors associated with vaccination status.
Vithiya Karunakaran, Ida Borreby Pedersen, Astrid Hjelholt, Mads Kjølby, Esben Thyssen Vestergaard, Ole Frøbert, Anders Aasted Isaksen, Kurt Kristensen   +7 more
wiley   +1 more source

Primary Care-Based Estimates of Influenza Vaccine Effectiveness in Hungary, 2024/25. [PDF]

Vaccines (Basel)
Túri G, Velkey V, Juhász KM, Krisztalovics K, Ferenczi A, Luca C, Bilics E, Kristóf K, Oroszi B.   +8 more
europepmc   +1 more source

To Treat or Not to Treat: Navigating Early‐Stage CLL in the Era of Targeted Therapy

European Journal of Haematology, EarlyView.
ABSTRACT Chronic lymphocytic leukemia (CLL) is most frequently diagnosed at early, asymptomatic stages (Rai 0/Binet A), in which a watch‐and‐wait strategy remains the standard of care, based on historical trials demonstrating no overall survival benefit from early treatment.
Enrica Antonia Martino, Santino Caserta, Ernesto Vigna, Giovanna Cutrona, Antonella Bruzzese, Francesco Mendicino, Maria Eugenia Alvaro, Caterina Labanca, Eugenio Lucia, Virginia Olivito, Nicola Amodio, Franco Fais, Antonino Neri, Manlio Ferrarini, Valter Gattei, Fortunato Morabito, Massimo Gentile   +16 more
wiley   +1 more source

Safety profile of India's influenza vaccine in a large-scale corporate vaccination drive. [PDF]

Hum Vaccin Immunother
Khatuja N, Aggarwal R, Dutta T, Mahajan M.   +3 more
europepmc   +1 more source

Influenza Vaccine and Associated Infection and Death in California, 2024 to 2025.

JAMA Netw Open
Zhu S, Quint J, León TM, Sun M, Li NJ, Yen C, Flannery B, Ellington S, Chung JR, Jain S, Schechter R, Hoover C, Murray EL.   +12 more
europepmc   +1 more source

Development of a pandemic H5N1 influenza vaccine using MDCK suspension cells: A scalable and efficient production platform. [PDF]

Hum Vaccin Immunother
Zhang S, Wang M, Jin D, Zhang J, Wang J, Ma Z, Yang J.   +6 more
europepmc   +1 more source

Simultaneous modification of Thermotoga maritima encapsulin subunits to produce multivalent nanoparticle vaccines for non‐typhoidal Salmonella enterica

The FEBS Journal, EarlyView.
This study investigates the modularity of encapsulin—a protein nanoparticle—by simultaneously inserting up to four distinct Salmonella epitopes within the encapsulin subunit. The encapsulin variants were transiently expressed in plants where they assembled into nanoparticles; however, their accumulation and stability varied depending on the ...
Carly A. Charron, Angelo Kaldis, Shabnam Shamriz, Moussa S. Diarra, Christopher P. Garnham, Rima Menassa   +5 more
wiley   +1 more source